Edit Symbol List
NVO: Stock Quote & Summary Data
| Last Sale | |
| Change Net / % |
|
| 1y Target Est: | N/A |
| Today's High / Low | / |
| Share Volume | |
| Previous Close | $ 66.10 |
| 52 Wk High / Low | $ 67.16 / $ 41.35 |
| Shares Outstanding | 37,163,000 |
| Market Value | $ 2,458,332,450 |
| P/E Ratio | 20.61 |
| Forward P/E (1yr) | N/A |
| Earnings Per Share | $ 3.21 |
| Annualized Dividend | $ 1.0345 |
| Ex Dividend Date | Mar. 19, 2009 |
| Dividend Payment Date | Mar. 31, 2009 |
| Current Yield | 1.56 % |
| Beta | 0.54 |
Intraday Chart |
| 5d | 1m | 6m | 12m | More Charting |
Have a Question About NVO?
Ask your question about about Novo Nordisk A/S (NVO) by typing it in the box below. You'll get direct responses from other members of the NASDAQ Answers community!
Hot Topics in NASDAQ Answers
The most popular questions & answers in the
NASDAQ Answers Community:
Company Description (as filed with the SEC)
Novo Nordisk A/S was formed in 1989 by a merger of two Danish companies, Nordisk Gentofte A/S and Novo Industri A/S. Novo Industri A/S was the continuing company and its name was changed to Novo Nordisk A/S. The business activities of Nordisk Gentofte A/S were established in 1923 by August Krogh, H. C. Hagedorn and A. Kongsted, and the business activities of Novo Industri A/S were established in 1925 by Harald and Thorvald Pedersen. The business of both companies from the beginning was production and sale of insulin for the treatment of diabetes. After spinning off an industrial enzyme business into the separate company Novozymes A/S in November 2000 Novo Nordisk A/S today is a focused healthcare company. ... More ...
Links to all Novo Nordisk A/S (NVO) Pages
Stock Analysis
Fundamentals
Holdings/Ownership
Company News for NVO |
||
|
Doctors Cite Time, Low Reimbursement As Barriers To Providing Comprehensive Diabetes Care, Survey Results Show - PR Newswire 11/19/2009 8:00AM |
||
|
Can This Stock Go Higher? - The Motley Fool 11/18/2009 1:48PM |
||
|
Secure Your Future Forever With These Stocks - The Motley Fool 11/17/2009 3:54PM |
||
|
Music to Health-Care Investors' Ears - The Motley Fool 11/16/2009 3:27PM |
||
|
Torrent To Produce Insulin Vials At Its New Facility For Novo Nordisk - RTT News 11/15/2009 10:32PM |
||
|
Shrugging Off the Side Effects - The Motley Fool 10/30/2009 3:57PM |
||
|
Novo Nordisk is Changing Possibilities in Hemophilia - PR Newswire 10/30/2009 9:00AM |
Consensus Recommendation |
|
|
Analyst Info |
|
| Annual EPS Est: | N/A |
| Quarterly EPS Est: | N/A |
| PEG Ratio: | N/A |
| Mean Recommendation: View Summary/View All |
N/A |



Symbol List Views
Stock Details
CHARTS
COMPANY NEWS
STOCK ANALYSIS
FUNDAMENTALS
HOLDINGS
0.08%
